We're sorry, but BRENDA doesn't work properly without JavaScript. Please make sure you have JavaScript enabled in your browser settings.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
The taxonomic range for the selected organisms is: Sus scrofa The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
Synonyms
guanylate cyclase, soluble guanylate cyclase, guanylyl cyclase, soluble guanylyl cyclase, npr-a, npr-b, particulate guanylate cyclase, h-nox, no receptor, guanylyl cyclase c,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
peptide hormone receptor guanylyl cyclase-C
-
Atrial natriuretic peptide A-type receptor
-
-
-
-
Atrial natriuretic peptide B-type receptor
-
-
-
-
GTP-pyrophosphate lyase
-
-
Guanylate cyclase
-
-
-
-
Guanylate cyclase 2D, retinal
-
-
-
-
Guanylate cyclase 2E
-
-
-
-
Guanylate cyclase 2F, retinal
-
-
-
-
Guanylate cyclase, olfactory
-
-
-
-
Intestinal guanylate cyclase
-
-
-
-
Rod outer segment membrane guanylate cyclase
-
-
-
-
soluble guanylate cyclase
-
-
soluble guanylyl cyclase
-
-
additional information
-
the enzyme is a member of the family of nucleotide cyclizing enzymes
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GTP = 3',5'-cyclic GMP + diphosphate
reaction mechanism, structure-function relationship
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
P-O bond cleavage
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GTP diphosphate-lyase (cyclizing; 3',5'-cyclic-GMP-forming)
Also acts on ITP and dGTP.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GTP
3',5'-cyclic GMP + diphosphate
GTP
3',5'-cyclic GMP + diphosphate
GTP
3',5'-cyclic-GMP + diphosphate
-
-
-
-
?
additional information
?
-
GTP
3',5'-cyclic GMP + diphosphate
guanylyl cyclase-C is a peptide hormone receptor
-
-
?
GTP
3',5'-cyclic GMP + diphosphate
guanylin-GC-C interaction, overview
-
-
?
GTP
3',5'-cyclic GMP + diphosphate
-
-
-
-
?
GTP
3',5'-cyclic GMP + diphosphate
-
sGC activity plays an important role in a variety of aspects of the cardiovascular system, regulatory mechanisms, overview. sGC has an anti-proliferative effect on smooth muscle cells
-
-
?
additional information
?
-
-
sGC mediates the NO-induced aqueous humor secretion and increased outflow facility from the eye
-
-
?
additional information
?
-
-
sGC role in vascular system diseases and failures, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GTP
3',5'-cyclic GMP + diphosphate
guanylyl cyclase-C is a peptide hormone receptor
-
-
?
GTP
3',5'-cyclic GMP + diphosphate
GTP
3',5'-cyclic-GMP + diphosphate
-
-
-
-
?
additional information
?
-
GTP
3',5'-cyclic GMP + diphosphate
-
-
-
-
?
GTP
3',5'-cyclic GMP + diphosphate
-
sGC activity plays an important role in a variety of aspects of the cardiovascular system, regulatory mechanisms, overview. sGC has an anti-proliferative effect on smooth muscle cells
-
-
?
additional information
?
-
-
sGC mediates the NO-induced aqueous humor secretion and increased outflow facility from the eye
-
-
?
additional information
?
-
-
sGC role in vascular system diseases and failures, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
-
complete inhibition at 0.001 mM
1H-[1,2,4]oxadiazolo[4,3a]quinoxalin-1-one
-
acute addition to pulmonary artery does not affect phenylephrine responsiveness, but restores the responsiveness in pulmonary artery treated with an NO-donor, overview
4H-8-bromo-1,2,4-oxadiazolo(3,4-d)benz(b)(1,4)oxazin-1-one
-
i.e. NS-2028, acts via the heme domain
6-anilino-5,8-quinolinedione
-
-
[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one
-
-
additional information
-
effects of activators and inhibitors on enzyme regulation, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A-350619
-
a heme-dependent stimulator of sGC, structurally not related to YC-1, but synergistic to YC-1 and sodium nitroprusside for the binding site, 70fold activation as sole stimulator, 160fold in presence of YC-1 and 230fold in presence of sodium nitroprusside
A-778935
-
i.e. cis-3-[2-(2,2-dimethyl-propylsulfanyl)pyridin-3-yl]-N-(3-hydroxycyclohexyl-)acrylamide, derived from the YC-1 structure, activates the enzyme is a synergistic fashion with the NO donor sodium nitroprusside
BAY 58-2667
-
activates the heme-free sGC 200fold, the activation is increased by inhibitor 1H-[1,2,4]oxidazolol[4,3a]quinoxalin-1-one
cinaciguat
-
cinaciguat activates the heme-free enzyme in a concentration-dependent manner with an EC50 value of about 0.2 microM and maximal cGMP formation at 10 microM. The compound causes time- and concentration-dependent relaxation of precontracted vessels with a maximal effect observed at 90 minutes. The dilatory response is not affected by extensive washout of the drug. Cinaciguat-induced vasodilation is associated with a time- and concentration-dependent increase of cGMP levels. The effect of cinaciguat on 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one-oxidized (ferric) soluble guanylate cyclase is moderate, reaching about 10%-15% of maximal activity
diethylenetriamine nitric oxide
-
-
G protein alpha subunit
-
-
-
HMR-1766
-
causes long-lasting decrease in systolic blood pressure
natriuretic peptide
-
-
-
sodium nitroprusside
-
synergistic to YC-1 and A-350619 for the binding site, 230fold activation in presence of A-350619
YC-1
-
synergistic with NO, blocked by 1H-[1,2,4]oxidazolol[4,3a]quinoxalin-1-one, from rats, synergistic to A-350619 and sodium nitroprusside for the binding site, 160fold activation in presence of A-350619
NO
-
-
NO
-
activates the soluble guanylate cyclase, the activation is abolished by 1H-[1,2,4]oxadiazolo[4.3a]quinoxalin-1-one
additional information
-
effects of activators and inhibitors on enzyme regulation, overview
-
additional information
-
NO treatment elevates the enzyme activity shortly after application, but does not significantly affect the steady-state levels of cGMP
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.29
-
pulmonary artery homogenate in absence of NO
0.53
-
pulmonary artery homogenate after 24 h of treatment with NO
1.38
-
pulmonary artery homogenate after 2 h of treatment with NO
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
UniProt
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GC-C
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
pulmonary
brenda
-
pulmonary, cultured model
brenda
-
coronary artery
brenda
-
-
brenda
-
anterior segment
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GC-C
brenda
-
-
-
brenda
-
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
physiological function
-
activation of sGC is involved in the nitric oxide-induced increases in outflow facility of the eye
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GUC2C_PIG
1073
2
123220
Swiss-Prot
Secretory Pathway (Reliability: 1 )
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
dimer
-
the enzyme is active as a heterodimer of alpha and beta subunits, but probably requires additional components for activity
additional information
homology structure modeling of the extracellular domain of GC-C, GC-C structure analysis by NMR and fluorescence emission spectroscopy, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
additional information
recombinant miniGC-C, comprising the exracellular enzyme domain, binds the heat-stable enterotoxin STp-(5-17) with high affinity, ligand binding and structure analysis, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
recombinant Trx-tagged miniGC-C, comprising the extracellular domain, from Escherichia coli strain AD494(DE3) by Co2+ affinity chromatography, dialysis and ultrafiltration, cleavage of the thioredoxin tag
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
expression of a Trx-tagged miniGC-C, comprising the extracellular domain, in Escherichia coli strain AD494(DE3) using expression vector pET-32a
overexpression in a baculovirus/Sf9 system
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Hasegawa, M.; Kawano, Y.; Matsumoto, Y.; Hidaka, Y.; Fujii, J.i.; Taniguchi, N.; Wada, A.; Hirayama, T.; Shimonishi, Y.
Expression and characterization of the extracellular domain of guanylyl cyclase C from a baculovirus and Sf21 insect cells
Protein Expr. Purif.
15
271-281
1999
Sus scrofa
brenda
Perkins, W.J.; Kost, S.L.; Danielson, M.A.
Prolonged NO treatment decreases alpha adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation
Am. J. Physiol. Lung Cell Mol. Physiol.
296
666-673
2009
Sus scrofa
brenda
Hoenicka, M.; Schmid, C.
Cardiovascular effects of modulators of soluble guanylyl cyclase activity
Cardiovasc. Hematol. Agents Med. Chem.
6
287-301
2008
Bos taurus, Canis lupus familiaris, Oryctolagus cuniculus, Homo sapiens, Mus musculus, Rattus norvegicus, Sus scrofa, Ovis aries (Q8SPV3)
brenda
Ellis, D.Z.; Dismuke, W.M.; Chokshi, B.M.
Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork
Invest. Ophthalmol. Vis. Sci.
50
1808-1813
2008
Homo sapiens, Sus scrofa
brenda
Lauber, T.; Tidten, N.; Matecko, I.; Zeeb, M.; Roesch, P.; Marx, U.C.
Design and characterization of a soluble fragment of the extracellular ligand-binding domain of the peptide hormone receptor guanylyl cyclase-C
Protein Eng. Des. Sel.
22
1-7
2009
Sus scrofa (P55204)
brenda
Kollau, A.; Opelt, M.; Woelkart, G.; Gorren, A.C.F.; Russwurm, M.; Koesling, D.; Mayer, B.; Schrammel, A.
Irreversible activation and stabilization of soluble guanylate cyclase by the protoporphyrin IX mimetic cinaciguat
Mol. Pharmacol.
93
73-78
2018
Sus scrofa
brenda